The use of CytoSorb® in a prasugrel‐loaded patient undergoing emergent coronary artery bypass graft surgery
Abstract Patients with acute coronary syndrome (ACS), failed percutaneous coronary intervention (PCI) and with an indication for emergent coronary artery bypass graft surgery (CABG) are at an increased risk of perioperative bleeding. Integration of the CytoSorb® (CS) adsorber into the cardiopulmonar...
Main Authors: | Erich Moresco, Hannes Dejaco, Volker Humbert, Matthias Thoma |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-03-01
|
Series: | Clinical Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/ccr3.6990 |
Similar Items
-
Use of CytoSorb® hemoadsorption column during prolonged cardiopulmonary bypass in complex cardiac surgery patient
by: Marianne Alarie, et al.
Published: (2022-07-01) -
CytoSorb removes MDMA in vitro, but is it an effective therapy in vivo?
by: Patrick M. Honore, et al.
Published: (2020-07-01) -
Impact of CytoSorb® on interleukin-6 in cardiac surgery
by: Daniela Geisler, et al.
Published: (2023-08-01) -
Hemoadsorption by CytoSorb in septic patients: a case series
by: Klaus Kogelmann, et al.
Published: (2017-03-01) -
Impact of CytoSorb Hemoadsorption Therapy on Fluid Balance in Patients with Septic Shock
by: Klaus Kogelmann, et al.
Published: (2024-01-01)